Lazard Asset Management LLC Purchases New Shares in C4 Therapeutics, Inc. (NASDAQ:CCCC)
Lazard Asset Management LLC bought a new position in C4 Therapeutics, Inc. (NASDAQ:CCCC – Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 22,693 shares of the company’s stock, valued at approximately $81,000. Other institutional investors have also recently made changes to […]
Lazard Asset Management LLC bought a new position in C4 Therapeutics, Inc. (NASDAQ:CCCC – Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 22,693 shares of the company’s stock, valued at approximately $81,000. Other institutional investors have also recently made changes to […]
